Similar articles for PMID: 18973991

Year	Number of Results
2003	1
2004	4
2005	2
2006	5
2007	12
2008	18
2009	20
2010	16
2011	9
2012	11
2013	11
2014	5
2018	2
2020	1
2024	0

1

Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.

Newcomer JW, Meyer JM, Baker RA, Eudicone JM, Pikalov A, Vester-Blokland E, McQuade RD, Crandall DT, Carson WH, Marcus RN, L'italien G. Newcomer JW, et al. Schizophr Res. 2008 Dec;106(2-3):300-7. doi: 10.1016/j.schres.2008.09.002. Epub 2008 Oct 29. Schizophr Res. 2008. PMID: 18973991 Free PMC article.

2

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.

Chrzanowski WK, Marcus RN, Torbeyns A, Nyilas M, McQuade RD. Chrzanowski WK, et al. Psychopharmacology (Berl). 2006 Dec;189(2):259-66. doi: 10.1007/s00213-006-0564-3. Epub 2006 Oct 21. Psychopharmacology (Berl). 2006. PMID: 17058105 Clinical Trial.

3

A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).

Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA; Schizophrenia Trials Network. Stroup TS, et al. Am J Psychiatry. 2011 Sep;168(9):947-56. doi: 10.1176/appi.ajp.2011.10111609. Epub 2011 Jul 18. Am J Psychiatry. 2011. PMID: 21768610 Free PMC article. Clinical Trial.

4

A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.

Newcomer JW, Campos JA, Marcus RN, Breder C, Berman RM, Kerselaers W, L'italien GJ, Nys M, Carson WH, McQuade RD. Newcomer JW, et al. J Clin Psychiatry. 2008 Jul;69(7):1046-56. doi: 10.4088/jcp.v69n0702. J Clin Psychiatry. 2008. PMID: 18605811 Clinical Trial.

5

The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.

Meyer JM, Rosenblatt LC, Kim E, Baker RA, Whitehead R. Meyer JM, et al. J Clin Psychiatry. 2009 Mar;70(3):318-25. doi: 10.4088/jcp.08m04267. Epub 2008 Dec 16. J Clin Psychiatry. 2009. PMID: 19192469

6

Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.

L'Italien GJ, Casey DE, Kan HJ, Carson WH, Marcus RN. L'Italien GJ, et al. J Clin Psychiatry. 2007 Oct;68(10):1510-6. doi: 10.4088/jcp.v68n1006. J Clin Psychiatry. 2007. PMID: 17960964

7

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH. McQuade RD, et al. J Clin Psychiatry. 2004;65 Suppl 18:47-56. J Clin Psychiatry. 2004. PMID: 15600384 Clinical Trial.

8

Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC. Henderson DC, et al. J Clin Psychopharmacol. 2009 Apr;29(2):165-9. doi: 10.1097/JCP.0b013e31819a8dbe. J Clin Psychopharmacol. 2009. PMID: 19512978 Free PMC article. Clinical Trial.

9

Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.

Jin H, Shih PA, Golshan S, Mudaliar S, Henry R, Glorioso DK, Arndt S, Kraemer HC, Jeste DV. Jin H, et al. J Clin Psychiatry. 2013 Jan;74(1):10-8. doi: 10.4088/JCP.12m08001. Epub 2012 Nov 27. J Clin Psychiatry. 2013. PMID: 23218100 Free PMC article. Clinical Trial.

10

Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.

Wang LJ, Ree SC, Huang YS, Hsiao CC, Chen CK. Wang LJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:260-6. doi: 10.1016/j.pnpbp.2012.10.010. Epub 2012 Oct 18. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23085073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year